Skip to main content Accessibility help
  • Print publication year: 2015
  • Online publication date: February 2015

21 - A young woman with a low AMH


1. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev 2006; 27(2): 170–207.
2. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 2006; 12(4): 333–40.
3. Feldburg D, Ashkenazi J, Dicker D, Yeshaya A, Goldman GA, Goldman JA.Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy. Fertil Steril 1989; 51: 42–4.
4. Yeh J, Barbieri RL, Ravnikar VA. Ovarian hyperstimulation associated with the sole use of leuprolide for ovarian suppression. J In Vitro Fert Embryo Transf 1989; 6(4): 261–3.
5. Weissman A, Barash A, Shapiro H, Casper RF. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone. Hum Reprod 1998; 13(12): 3421–4.
6. Qublan HS, Beni-Merei Z, Megdadi M, Al-Quraan G. Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases. Arch Gynecol Obstet 2009; 279(2): 221–3.
7. Azem F, Almog B, Ben-Yosef D, Kapustiansky R, Wagman I, Amit A. First live birth following IVF-embryo transfer and use of GnRHa alone for ovarian stimulation. Reprod Biomed Online 2009; 19(2): 162–4.